Akèy › Obèsite › Kalifòni › Los Angeles
Etid klinik pou Obèsite nan Los Angeles, CA
23 etid pou Obèsite ap chèche patisipan nan sit nan ak bò kote Los Angeles (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Ap rekriteFaz 2
- Los Angeles Institute for Metabolic Research /ID# 282059, Los Angeles
Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients
Ap rekrite
- Cedars Sinai Medical Center, Los Angeles
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Ap rekriteFaz 3
- Childrens Hospital of Los Angeles, Los Angeles
- UCLA Mattel Children's Hospital, Los Angeles
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Ap rekriteFaz 3
- Inglewood Clinical, Los Angeles
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Ap rekriteFaz 3
- AURORA-2 Clinical Site, Los Angeles
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Ap rekriteFaz 3
- AURORA-1 Clinical Site, Los Angeles
Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
Ap rekriteFaz 3
- Los Angeles Institute for Metabolic Research, Los Angeles
Effects of Dietary Supplements on Muscle Mass and Function While Using GLP-1 Medication
Ap rekriteVolontè an sante akeyi
- UCLA Center for Human Nutrition, Los Angeles
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Ap rekriteFaz 4
- Metropolis Dermatology, Los Angeles
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
Ap rekriteFaz 2
- Children's Hospital Los Angeles, Los Angeles
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Ap rekriteFaz 3
- VAGrtrLosAngelesHlthcareSystem, Los Angeles
A Study to See if an iPhone Weight Management App Can Help Promote Weight Loss in Adolescents and Young Adults After a Stem Cell Transplant
Ap rekriteVolontè an sante akeyi
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use
Ap rekriteFaz 3Volontè an sante akeyi
- Vanda Investigational Site, Los Angeles
Probiotic Intervention Study
Ap rekriteVolontè an sante akeyi
- University of California, Los Angeles
Single Nuclei RNA-seq to Map Adipose Cellular Populations and Senescent Cells in Older Subjects
Ap rekriteFaz 2/3Volontè an sante akeyi
- Cedars Sinai Medical Center, Los Angeles
Avoid and Resist Strategies for Weight Management
Ap rekriteVolontè an sante akeyi
- Cedars-Sinai Medical Center, Los Angeles
FEAST Perinatal Support Program Intervention
Ap rekrite
- University of Southern California, Los Angeles
Behavioral Weight Loss Intervention Utilizing Mobile Health Technology in Hematopoietic Stem Cell Transplant Patients
Ap rekriteVolontè an sante akeyi
- UCLA Mattel Children's Hospital, Los Angeles
BrainWeighve App Feasibility Study
Ap rekriteVolontè an sante akeyi
- UCLA Marion Davies Children's Center, Los Angeles
eMOTION: Examining Implicit Attitudes in Physical Activity Engagement
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Univeristy of Southern California, Los Angeles
Tirzepatide for Alcohol Use Disorder
Ap rekriteFaz 2
- Keck School of Medicine, University of Southern California, Los Angeles
eMOTION: Examining Affective Mechanisms in Physical Activity Engagement
Ap rekriteVolontè an sante akeyi
- University of Southern California, Los Angeles
Brown Adipose Tissue Activity in Response to Semaglutide Administered to Obese Subjects.
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- UCLA Health, Los Angeles
Etid Obèsite nan lòt vil
- Houston, TX43 etid
- Chicago, IL41 etid
- New York City, NY40 etid
- San Antonio, TX40 etid
- Washington, DC33 etid
- Orlando, FL32 etid
- Dallas, TX30 etid
- Boston, MA28 etid
- Las Vegas, NV27 etid
- Miami, FL27 etid
- Baltimore, MD26 etid
- Jacksonville, FL25 etid
Lòt etid nan Los Angeles
- Kansè Poumon ki pa ti selil87 etid
- Kansè (tout kalite)74 etid
- Kansè nan tete73 etid
- Kansè pwostat61 etid
- Kansè kolorektal59 etid
- Kansè Metastatik57 etid
- Kansè ovè50 etid
- Kansè poumon45 etid
- Karsinòm selil skuamèz tèt ak kou42 etid
- Kansè pankreyas35 etid
- Kansè Endomèt34 etid
- Melanom34 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.